Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.

Human gene therapy·2026

Same author

The Earth BioGenome Project Phase II: illuminating the eukaryotic tree of life.

Frontiers in science·2026

Same author

A two-tier framework for responsible research on human embryo models.

Cell·2026

Same author

Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited.

Stem cell reports·2025

Same author

Navigating the impact of the 21st-Century Cures Act Final Rule: A national cross-sectional survey of US genetic counselors.

Journal of genetic counseling·2025

Same author

Workplace Genomic Testing: What Do Company Websites Say about Federal Privacy and Anti-Discrimination Laws?

Public health genomics·2025

Search research articles

Related Experiment Video

Updated: May 28, 2026

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

Promoting justice in stem cell intellectual property.

Alan Regenberg¹, Debra J H Mathews

¹Johns Hopkins Berman Institute of Bioethics, 1809 Ashland Avenue, Baltimore, MD 21205, USA.

Regenerative Medicine

|October 18, 2011

Summary

Intellectual property rights (IPR) incentivize innovation by granting creators exclusive rights in exchange for public disclosure. This paper examines IPR and innovation policy models within stem cell science.

Area of Science:

Biotechnology
Medical Research
Intellectual Property Law

Background:

Intellectual property rights (IPR) grant creators exclusive control over their innovations for a set period.
The core principle of IPR is a quid pro quo: exclusivity for creators in exchange for public disclosure to foster further innovation.
Patents and licenses are primary mechanisms for managing IPR, with national regulations often governing patenting.

Purpose of the Study:

To analyze the role and impact of intellectual property rights (IPR) within innovation policy.
To specifically explore the complexities of IPR and innovation policy models in the field of stem cell science.
To highlight factors making stem cell science a critical context for examining these issues.

Main Methods:

More Related Videos

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Published on: November 26, 2014

Related Experiment Videos

Last Updated: May 28, 2026

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Published on: November 26, 2014

Literature review of intellectual property rights frameworks.

Analysis of existing innovation policy models.

Case study focus on stem cell science to contextualize IPR challenges.

Exploration of alternative IPR management strategies like patent pooling and open-source licenses.

Main Results:

IPR are a dominant force in science innovation policy, balancing creator incentives with public access to knowledge.
Various alternative and modified IPR models exist, including patent pools, exchanges, and open-source licenses.
Stem cell science presents unique challenges and considerations for IPR and innovation policy due to its rapid advancement and therapeutic potential.

Conclusions:

The established intellectual property rights framework, while spurring innovation, necessitates careful consideration within rapidly evolving scientific fields like stem cell research.
Alternative and flexible IPR models may be crucial for balancing innovation, access, and ethical considerations in stem cell science.
Understanding the interplay of IPR and innovation policy is vital for maximizing the societal benefits of stem cell discoveries.